Tools   Select Another Resource Report Type

http://www.scienceexchange.com/facilities/zyagen

A commercial service organization from Zyagen.

Proper citation: Zyagen (RRID:SCR_005295) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/edgebio

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. A contract research organization that provides genomics services such as sequencing, bioinformatics, NGS data analysis and whole exome sequencing. EdgeBio is a CLIA-approved service provider.

Proper citation: EdgeBio (RRID:SCR_000183) Copy   

•   Source: SciCrunch Registry

https://www.qcif.edu.au/

Provides digital infrastructure capabilities for research and innovation across Queensland and Australia. Provides services, infrastructure and support for computation and data driven collaborative research and its application in industry. Members are six Queensland universities – The University of Queensland, Queensland University of Technology, Griffith University, James Cook University, CQUniversity, and the University of Southern Queensland. The University of the Sunshine Coast is an associate member. Member employees provide support and development services.

Proper citation: Queensland Cyber Infrastructure Foundation Ltd (RRID:SCR_000208) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/genomics-services-lab

A lab that offers genetic research tools such as RNA sequencing and a variety of arrays.

Proper citation: HudsonAlpha Genomics Services Lab (RRID:SCR_000353) Copy   

•   Source: SciCrunch Registry

http://www.lonza.com/

A supplier of various biochemical products for research in pharmacy and biotechnology as well as the specialty ingredients market. Examples of products include active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers and agriculture services and products.

Proper citation: Lonza (RRID:SCR_000377) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/macquarie-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 23,2023. Set of facilities based out of Macquarie University in New South Wales. Some facilities provide services such as proteome analysis or resources of various academic departments like engineering, biological sciences, and geography.

Proper citation: Macquarie University Labs and Facilities (RRID:SCR_000944) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/4904

A contract research organization based in India that provides services including Clinical Development, Contract Manufacturing and Informatics.

Proper citation: GVK Biosciences Labs and Facilities (RRID:SCR_001044) Copy   

•   Source: SciCrunch Registry

http://www.ohri.ca/FacilitiesAndServices/

Portal to research facilities and services within the Ottawa Hospital Research Institute. Facilities and services include access to their bioinformatics facility, flow cytometry facility, human pluripotent stem cell facility, and their clinical research lab.

Proper citation: Ottawa Hospital Research Institute Labs and Facilities (RRID:SCR_001045) Copy   

•   Source: SciCrunch Registry

https://www.petermac.org/research/labs/grant-mcarthur

Cancer research laboratory at the Peter MacCallum Cancer Centre which investigates biomarkers identification, compounds for activity as anti-cancer drugs, and small molecule targeted therapies.

Proper citation: Translational Research Laboratory (RRID:SCR_001023) Copy   

•   Source: SciCrunch Registry

http://www.ark-genomics.org/

Portal for studies of genome structure and genetic variation, gene expression and gene function. Provides services including DNA sequencing of model and non-model genomes using both Next Generation and Sanger sequencing , Gene expression analysis using both microarrays and Next Generation Sequencing, High throughput genotyping of SNP and copy number variants, Data collection and analysis supported in-house high performance computing facilities and expertise, Extensive EST clone collections for a number of animal species, all of commercially available microarray tools from Affymetrix, Illumina, Agilent and Nimblegen, Parentage testing using microsatellites and smaller SNP panels. ARK-Genomics has developed network of researchers whom they support through each stage of their genomics research, from grant application, experimental design and technology selection, performing wet laboratory protocols, through to analysis of data often in conjunction with commercial partners.

Proper citation: ARK-Genomics: Centre for Functional Genomics (RRID:SCR_002214) Copy   

•   Source: SciCrunch Registry

https://oligofactory.com/

Provides oligonucleotides. Synthesizes custom DNA/RNA oligonucleotides for scientific and therapeutic communities.

Proper citation: Oligo Factory (RRID:SCR_012567) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/duke-university

An Portal, Core facility

Proper citation: Duke University Labs and Facilities (RRID:SCR_012445) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/am-biotechnologies-llc

AM Biotechnologies develops DNA-based affinity agents called thioaptamers using unique chemistries and a proprietary bead-based selection process. Antibodies are currently the most widely-used affinity agents but they are produced in animals; are easily degraded; are expensive to produce; and suffer from batch-to-batch variability. In contrast, thioaptamers are chemically synthesized; they are stable in ambient environments with very long shelf life; and are rapidly produced in large quantities with easy quality control. We solve the problems associated with antibodies while delivering the same functionality. Thioaptamers can be substituted for antibodies in virtually any application. We can develop thioaptamer affinity agents for your targets using our bead-based development service. AM also offers DNA thiophosphoramidite reagents via a strategic partnership with Glen Research Corporation and the RNA thiophosphoramidites are near market introduction. These unique reagents are used to synthesize thioaptamers and are also highly useful for providing in vivo stability and increased potency in RNAi applications. The company was founded in 2006 and is primarily owned by two corporations. It has been awarded numerous SBIR grants and has also benefited from over $10M of prior university research into its technologies. Importantly, all of our technologies have freedom to operate.

Proper citation: AM Biotechnologies (RRID:SCR_012568) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/trevigen

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 19,2024. Trevigen Cell Assays (TCA), a division of Trevigen, Inc., was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the medical research market. TCA specializes in designing and conducting assays for lead compounds and genotoxic screening based on DNA damage and repair as well as cancer cell behavior.

Proper citation: Trevigen Cell Assays (RRID:SCR_012449) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-nebraska-medical-center

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, core facility.

Proper citation: University of Nebraska Medical Center Labs and Facilities (RRID:SCR_012451) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/suny-at-stony-brook

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 23,2024. Portal, Core facility

Proper citation: SUNY at Stony Brook Labs and Facilities (RRID:SCR_012455) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/advanced-bioscience-laboratories

Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, partnering with our clients to advance their vaccine and therapeutic development programs. Our unique combination of preclinical and clinical services provide the tools to address the scientific challenges encountered during any stage of product development. For preclinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. Once a clinical candidate is identified, ABL''s in-house cGMP suites are designed for single-use technologies accommodating a wide range of products, including mammalian- and microbial-based protein therapeutics as well as viral vectors and vaccines.

Proper citation: Advanced BioScience Laboratories (RRID:SCR_012576) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-rochester

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, Core facility

Proper citation: University of Rochester Labs and Facilities (RRID:SCR_012454) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/cornell-university

An Portal, Core facility

Proper citation: Cornell University Labs and Facilities (RRID:SCR_012457) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/the-ohio-state-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 22, 2024. Portal, Core facility

Proper citation: Ohio State University Labs and Facilities (RRID:SCR_012462) Copy   

•   Source: SciCrunch Registry